Press release
Anti-Obesity Prescription Drugs Market to 2017 - 2026: VIVUS, Inc, Orexigen Therapeutics, Inc, Novo Nordisk A/S, F Hoffmann La Roche Ltd Arena Pharmaceuticals, Inc
Global Anti-Obesity Prescription Drugs Market: Overview
The global anti-obesity prescription drugs market is expected to witness a moderate growth attributed to growing prevalence of obesity globally. Moreover, surge in consumption of unhealthy food products that are rich in cholesterol has led to an upsurge in demand anti-obesity prescription drugs. Increasing level of chronic stress also contributes towards obesity. Moreover, consumption of psychotropic and diabetic drugs is expected to impact growth of the global anti-obesity prescription drugs market during the forecast period.
The report provides an in-depth insight on some important aspects of the global anti-obesity prescription drugs market and offers insights on the growth patterns, various factors fuelling growth of the global market, competitive landscape and important segments.
To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1391914
Global Anti-Obesity Prescription Drugs Market: Dynamics
Growth of the global anti-obesity prescription drugs market will mainly remain bound to various macro-economic and micro-economic factors. The report further reveals that the global anti-obesity prescription drugs market is increasingly driven by growing prevalence of obesity globally. Consumption of the food products that are rich in cholesterol continues to contribute towards obesity. Growing consumption of alcoholic beverages will also lead to increase in obesity during the forecast period.
Growing prevalence of depression has led to increasing consumption of the psychotropic drugs. Increasing side-effects of the psychotropic drug has contributed towards obesity. Growing prevalence of obesity due to increasing side-effects of psychotropic drugs has led to an upsurge in demand for obesity management. Moreover, increasing prevalence of diabetes has revved up consumption of medications such as sulfonylureas, insulin and thizolidinediones. These medications have appetite stimulating features, due to which the patients tend to eat more. Eating disorders due to antidepressants and diabetic drugs has continued to contribute towards obesity. Increasing demand for obesity management is expected to impact growth of the global anti-obesity prescription drugs market positively.
Obesity has also witnessed to be a result of increasing chronic stress globally. Increasing emotional and physical stress level leads the brain to release cortisol hormones. Release of the cortisol hormones further stimulates a persons appetite, due to which people tend to eat unhealthy food products. Increasing consumption of unhealthy food products helps people to counter their emotional and physical stress. Growing prevalence of obesity due to increasing level of stress has further led to an upsurge in demand for obesity management. Bound to these factors, the global anti-obesity prescription drugs market is expected to witness significant growth.
Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/anti-obesity-prescription-drugs-market-global-industry-analysis-size-share-growth-trends-and-forecast-2017-2026-report.html/toc
Global Anti-Obesity Prescription Drugs Market: Segmentation
The global anti-obesity prescription drugs market is mainly segmented into drug class, age group, distribution channel, and region. On the basis drug class, the global market is expected to be segmented as Bupropion and Naltrexone, Orlistat, Lorcaserin, Phentermine and Topiramate and Liraglutide. Based on age group, the global market is segmented as Pediatric and Adult. By distribution channel, the global market is segmented as Hospitals Pharmacies, Retail Pharmacies and E-commerce.
Global Anti-Obesity Prescription Drugs Market: Competition
Key players in the global anti-obesity prescription drugs market are VIVUS, Inc, Orexigen Therapeutics, Inc, Novo Nordisk A/S, F Hoffmann La Roche Ltd and Arena Pharmaceuticals, Inc.
Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=1391914
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on @ https://marketsizeinfo.blogspot.in/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anti-Obesity Prescription Drugs Market to 2017 - 2026: VIVUS, Inc, Orexigen Therapeutics, Inc, Novo Nordisk A/S, F Hoffmann La Roche Ltd Arena Pharmaceuticals, Inc here
News-ID: 1519251 • Views: …
More Releases from Anti-Obesity Prescription Drugs market
New Business Opportunities of Anti-Obesity Prescription Drugs market in Global I …
Researchmoz added Most up-to-date research on "Asia-Pacific Anti-Obesity Prescription Drugs Market Report 2017" to its huge collection of research reports.
In this report, the Asia-Pacific Anti-Obesity Prescription Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report split Asia-Pacific into several key Regions, with sales (K…
More Releases for Obesity
Anti-Obesity Drugs Market Grows Rapidly, Driven by Obesity Rates and Therapeutic …
Anti-Obesity Drugs Market valued at USD 5.9 Bn in 2024, growing at 16.5% CAGR to reach USD 20.02 Bn by 2032. Driven by GLP-1 therapies and rising obesity rates.
Anti Obesity Drugs Market Overview:
The anti-obesity drugs market is undergoing significant transformation as awareness about obesity-related health risks rises globally. With growing concern over lifestyle-related disorders, there is an increasing emphasis on medical intervention as a complement to traditional weight management strategies.…
Fuzzle joins The Obesity Society & The Obesity Action Coalition; Promotes Habit- …
Building healthy, sustainable habits for long-term weight management success.
Tampa, FL - March 18, 2025 - Fuzzle, an emerging leader in the wellness landscape, is pleased to announce that it's now a Member of The Obesity Society, as well as the Obesity Action Coalition, marking a new milestone in the company's mission to transform how individuals approach weight loss.
Image: https://www.globalnewslines.com/uploads/2025/03/77da787ae98a633847c70fc22e2943c7.jpg
Fuzzle supports individuals in their wellness journey through non-invasive, drug-free strategies. With…
Pediatric Obesity Management Market - Healthy Habits for Life: Advancing Pediatr …
Newark, New Castle, USA: The "Pediatric Obesity Management Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Pediatric Obesity Management Market: https://www.growthplusreports.com/report/pediatric-obesity-management-market/8930
This latest report researches the industry structure,…
Anti-Obesity Drugs Market - From Obesity to Vitality: Leading the Way in Effecti …
Newark, New Castle, USA - new report, titled Anti-Obesity Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Anti-Obesity Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Anti-Obesity Drugs market. The report offers an overview of the market, which…
Increasing Prevalence of Obesity Driving Obesity/Bariatric Surgery Devices Marke …
The global obesity/bariatric surgery devices market revenue stood at $1.4 billion in 2016, and it is expected to rise to $2.8 billion by 2023. Furthermore, the market will progress at a CAGR of 9.9% from 2017 to 2023 (forecast period), as per the estimates of the market research company, P&S Intelligence. The major growth drivers of the market are the rising incidence of obesity, owing to unhealthy diets and lifestyle…
Fast Food and Obesity
Most of the fast food in the market contains a large quantity of sugar, #carbs and fats with a lesser quantity of vitamins and minerals. The unhealthy food ingredients in the fast food are further increased with increased portion size. The person will still consume the whole meal regardless of being completely full. People cannot stop ravishing on fast food because it is available for low cost and in close…
